Fresenius SE & Co. KGaA (FRA:FRE – Get Free Report)’s stock price traded up 1.1% on Monday . The company traded as high as €38.08 and last traded at €37.67. 861,281 shares were traded during trading, The stock had previously closed at €37.25.
Fresenius SE & Co. KGaA Stock Performance
The business has a 50 day moving average price of €40.07 and a two-hundred day moving average price of €45.29.
About Fresenius SE & Co. KGaA
Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients.
See Also
- Five stocks we like better than Fresenius SE & Co. KGaA
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
